Given the emergence of COVID-19, in the last two years, remarkable progress has been made in understanding CD8+ T-cell responses against SARS-CoV-2, and in vivo models have shown that CD8+ T cells are able to protect from the development of severe COVID-19 [39,40]. The gene discussed is CD8A; the disease is COVID-19.